alexa Bethametasone Prevents Plasmatic Glutamine Precipitation: An In-Vivo Study | Open Access Journals
ISSN: 2155-6148
Journal of Anesthesia & Clinical Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Bethametasone Prevents Plasmatic Glutamine Precipitation: An In-Vivo Study

Maria Caterina Pace1, Maria Beatrice Passavanti1, Antonio Palagiano1, Fabio Arturo Iannotti2, Vincenzo Pota1, Antonietta Messina3, Pasquale Sansone1, Leonardo Pace1, Pasquale Carfora1, Giovanni Messina3, Marcellino Monda3* and Caterina Aurilio1

1Department of Anesthesiological, Surgical and Emergency Sciences, Second University of Naples, Italy

2Institute of Biomolecular Chemistry (ICB), National Council of Research (CNR), Pozzuoli (NA), Italy

3Department of Experimental Medicine, Section of Human Physiology, and Clinical Dietetic Service, Second University of Naples, Italy

*Corresponding Author:
Prof. Marcellino Monda, MD
Department of Experimental Medicine
Section of Human Physiology, and Clinical Dietetic Service
Second University of Naples, Via Costantinopoli 16
80138 Naples, Italy
Tel: +39 +81 5665804
Fax: +39 +81 5665841
E-mail: [email protected]

Received date: April 22, 2015; Accepted date: May 29, 2015; Published date: May 30, 2015

Citation: Pace MC, Passavanti MB, Palagiano A, Iannotti FA, Pota V, et al. (2015) Bethametasone Prevents Plasmatic Glutamine Precipitation: An In-Vivo Study. J Anesth Clin Res 6:531. doi: 10.4172/2155-6148.1000531

Copyright: © 2015 Pace MC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Anesthesia & Clinical Research

Abstract

Glutamine (Gln) is an amino acid which plays an important regulatory role in many physiological functions and during acute or chronic human pathologies. The primary purpose of this study was to investigate potential changes of glutamine levels in the plasma of women that needed minor gynaecological surgery. The changes in glutamine levels were then evaluated in a group of patients pre-medicated with Bethametasone. In this study 46 patients were subdivided into two groups. All of them were anesthetized with loco-regional administration of mepivacaine 0.2%. Subsequently, to the first group was given placebo, whereas the second group of women was pre-medicated with Bethametasone 4 mg (i.v.). We report that in 34 patients out of 46, the minor gynaecologic surgery caused a significant decrease of glutamine (>20%) associated with an increase of postoperative pain. Interestingly, 10 out of 12 patients received Betamethasone, had increased levels of glutamine (>25%) and the use of analgesic drugs in the postoperative time was not required. In conclusion, in this study we found that minor gynaecological surgery causes a significant decrease of plasma level of glutamine that is associated with increase of postoperative pain. In contrast, the premedication with Betamethasone increases the plasma levels of glutamine, correlating with a good control of postoperative pain.

Keywords

Glutamine (Gln); Bethametasone; Ginecological surgery

Introduction

Glutamine is one of the most abundant non-essential amino acid of human body with a role in numerous biological functions including the immune system responses [1-4], glucose metabolism [5-8], lipogenesis [9], muscular skeletal tropism [10-11], cell cycle regulation and apoptosis [12] etc.

In the body, once synthetized, Gln is converted to glutamic acid (or glutamate) and glutathione [13]. The glutamic acid is the main excitatory neurotransmitter in the central nervous system. It plays a pivotal role in regulating key neurological functions including the neuronal excitability, synaptic plasticity, long term potentiation and depolarization etc. [14-17]. On the other hand, the glutathione possesses important anti-oxidant proprieties that counteract oxidative stress [13,18-22].

Many studies have shown positive effects of glutamine on some painful syndromes and particularly it can prevent pain in patients suffering from stomatitis, or mucositis of gastrointestinal tract caused by chemotherapy and radiotherapy [23], as well as on some forms of arthralgia and myalgia caused by paclitaxel [24].

Glutamine is also a marker of physical stress, in fact its plasmatic reduction increases the inflammatory cytokines released during surgery.

Based on these considerations, the supplementation of glutamine showed significant beneficial effects in several human disorders. In fact, it has been widely reported that the Gln reinforces the activity of the immune-system [25], reduces the synthesis of pro-inflammatory cytokine, induces the expression of heat shock proteins, prevents the cell death [26,27] and ameliorates the brain functions [28]. Moreover, in patients that require critical care glutamine supplementation reduced inflammatory systemic syndrome (SIRS) and the risk of sepsis [29-33].

According to what we have said and to its biologic properties, even its depletion, caused by surgical and/or anaesthesia stress, could be contrasted by preventive glutamine administration, reducing recovery times and post-operative complications, as we have observed in numerous studies on patients operated for colon-rectal cancer [17,34,35].

In spite of its importance, the potential changes of plasma Gln levels caused by gynaecological surgeries as well as the type of anesthesia carried out, has not yet been established.

Therefore the aim of this study is to evaluate the potential changes in the plasma level of glutamine in patients undergoing minor gynaecological surgery, in local anesthesia with paracervical block [36], premedicated or not with Bethametasone.

Materials and Methods

Clinical and surgical procedures

After approval by the local ethics committee n. 318/2008 and signed informed consent, at the gynaecological day surgery of the Second University of Naples, for this study we have recruited 46 women, aged 18–63 with ASA physical status I–II, needed gynecologic or obstetric surgery that were randomly assigned, by a computer-generated randomization list, to the betamethasone treatment (group B) or placebo (group P).

The patients belonging to the group P, after premedication with Atropine (0.5-0.8 mg/Kg) and Fentanyl (0.5-0.1 mg/Kg) was administered placebo; whereas the group B of patients received bethametasone (4 mg).

All patients were anaesthetized by para-cervical block by loco-regional injection of mepivacaine 0.2% (10 ml). During the paracervical block, the Lee-Frankenauser ganglion, where the sensory visceral nerve fibers of the uterus, cervix, and part of the bladder converge, was blocked. A 22-G, 10-cm long needle, was introduced only 5–7 mm into the submucosa of the lateral fornices to reduce the risk of intravascular injection. After controlled aspiration, the local anesthetic was injected (5 mL for each fornix).

After paracervical block and before surgery, we slowly administered a bolus of propofol (0.5–0.7 mg/kg) to women in both groups, according to the type of surgery and individual needs.

Patients spontaneously breathed and in all of them the main vital parameters (ECG, heart rate, arterial blood pressure and oxygen saturation) were monitored.

In all patients the pain score was measured by VAS (Visual Analogical Scale) method (0 reflects no pain and 100 unbearable pain) at the end of surgery, after one hour and at discharge, by an anesthesiologist who was unaware of drugs administered.

In case of postoperative pain, 1 g of paracetamol was administered i.v.

The patient’s degree of satisfaction was evaluated on discharge with a score of 0–4: 0=poor, 1=fair, 2=good, 3=very good, and 4=excellent.

In each patient, the plasma levels of glutamine was measured by the blood analysis before (Sample A) and after surgery (Sample B), in both cases in a haemachrome test tube EDTA as anti-coagulant, to measure out glutamine with high-performance liquid chromatography and creatinine.

Data analysis

Sample size calculation was performed using a statistical power analysis: an estimated 40 patients were needed to result in a 90% chance of detecting a difference between groups in pain incidence respect glutamina deplection during surgical procedures conducted under conscious sedation with peripheral block, with an error of 5%, a difference from baseline of 15%, and a standard deviation of 0.5.

The levels of Gln in the blood sample A and B of each patient (see method section) were compared by use of matched Student’s t tests and expressed in % ± SEM. Statistically significant differences were accepted when the p value was ≤ 0.05 (Iannotti et al. 2013).

Results

Patients’ characteristics were similar in both groups. Subjects were randomized in group B (N=23) and Group P (N=23). No statistical differences were observed for age, weight, ASA physical status, or parity (Table 1).

In all patients the renal function did not showed anomalies.

Hospitalization never exceeded the expected duration. There were no significant changes in the monitored parameters.

No significant side effects or complications appeared. We did not administered oxygen beyond expected time.

Age (years) (mean ± SD) Group B 34 ± 12 Group P 34 ± 11
ASA I 18 16
ASA II 5 7
Multiparous 8 10
Nulliparous 15 13
Weight (Kg) (mean ± SD) 63 ± 15 65 ± 14

Table 1: Characteristics of the two groups studied.

Interestingly, when the two blood samples were compared, we found that in 34 patients out of 46, the gynaecological surgery caused a significant decrease of plasma levels of glutamine (Figure 1, Tables 2 and 3). In particular, 18 patients out of 23 belonging to the placebo group showed a reduction of Gln >20%; while in 3 patients the decrease of Gln was less strong. In the remaining 2 patients belonging to this group, the Gln level was increased.

anesthesia-clinical-research-Plasmatic-levels

Figure 1: Plasmatic levels of glutamine from in patients pre-medicated or not with bethametasone. Plasmatic levels of glutamine were measured before and after the surgical intervention in patients pre-medicated or not with betametasone. The bar graphs show the % of glutumine increase or reduction between the two groups. Each data point is the mean ± S.E.M calculated from the two separate group. Asterisks denote values significantly different (p ≤ 0.05).

Patient: Time of surgery (min) Gln conc (sample A) Gln conc (sample B) Gln variation Gln variation (%) Creatinine (mg/dL)
1 5 2.3 1.69 reduced 26 0.6
2 8 2.04 1.61 reduced 21 0.54
3 11 2.1 1.65 reduced 21.4 0.45
4 6 1.98 1.53 reduced 22.7 0.78
5 12 2.56 2.01 reduced 21.5 0.69
6 10 1.99 1.24 reduced 37.6 0.64
7 11 2.02 1.53 reduced 23.8 0.74
8 11 2.6 2.01 reduced 22.6 0.82
9 8 2.45 1.33 reduced 45.7 0.72
10 9 2.68 1.08 reduced 59.7 0.7
11 9 2.79 1.74 reduced 43.7 0.7
12 7 2.34 1.57 reduced 32.9 0.64
13 8 2.88 2.07 reduced 28 0.67
14 11 2.53 1.77 reduced 30 0.54
15 13 2.64 2.02 reduced 23.4 0.56
16 14 2.22 1.63 reduced 22.2 0.73
17 15 2.08 1.55 reduced 23.2 0.7
18 9 2.2 1.56 reduced 29 0.6
19 7 2.3 2 reduced 13 0.6
20 9 2.04 1.71 reduced 16 0.6
21 5 2.1 1.8 reduced 14 0.69
22 8 2.31 2.69 increased 16.4 0.5
23 7 2.01 2.4 increased 19.4 0.6

Table 2: Plasmatic levels of glutamine measured in patients belonging to the placebo group.

Patient: Time of surgery (min) Gln conc (sample A) Gln conc (sample B) Gln variation Gln variation (%) Creatinine (mg/dL)
1 5 2.6 3.2 increased 23 0.53
2 8 2.01 1.61 increased 29 0.52
3 8 2.1 2.64 increased 26.2 0.6
4 9 2.67 3.43 increased 31.7 0.6
5 12 2.4 3.01 increased 25.4 0.84
6 11 1.9 2.34 increased 23.1 0.72
7 10 2.11 3.53 increased 67.2 0.7
8 11 2.26 3.01 increased 33.2 0.81
9 10 2.5 3.03 increased 21.2 0.73
10 5 2.67 3.28 increased 22.3 0.69
11 9 3.01 2.6 reduced 15.7 0.6
12 6 2.03 1.77 reduced 12.8 0.6
13 8 1.93 1.67 reduced 13.4 0.6
14 9 2.03 1.81 reduced 10.8 0.64
15 8 2.4 2.02 reduced 15.8 0.7
16 5 2.02 1.65 reduced 18.3 0.85
17 6 2.18 1.75 reduced 19.7 0.64
18 8 3.02 2.56 reduced 15.2 0.7
19 9 2.4 1.82 reduced 24.1 0.72
20 12 3.03 2.31 reduced 24 0.63
21 15 2.2 1.63 reduced 25.6 0.61
22 6 2.32 1.59 reduced 31.4 0.7
23 13 2.23 1.4 reduced 59.2 0.72

Table 3: Plasmatic levels of glutamine measured in patients pre-medicated with bethametasone.

In contrast, 10 patients out of 23 pre-medicated with betamethasone an increase of glutamine concentration >20% was observed. Whilst, in 8 patients we observed a decrease of Gln by about <20%. In the remaining 5 patients, the reduction of Gln was larger than >20%.

Interestingly, 10 patients belonging to the placebo group with decreased levels of Gln, declaimed post-operative pain (VAS >30) within the first hour after surgery (Table 4). In this case, 1 gm Paracetamol (i.v.) was administered. In contrast, for those patients pre-medicated with betamethasone showing increased levels of Gln, the use of analgesic drugs was not necessary (VAS <30, Table 4).

The degree of satisfaction was better in Group B (group B: 5 ± 0.9 vs. group P: 3.6 ± 0.8). The results are summarized in Table 4.

However, upon an accurate clinical observation (4-6 h) and once reached a complete clinical recovery, the patients were discharged.

 VAS Group B Scores Group P Scores
0 <30 >30 0 <30 >30
Pain during surgery 23 - - 23 - -
Pain 1 h after surgery 20 3 - 11 2 10
Pain on discharge 22 1 - 17 6 - -
Degree of satisfaction   5 ± 0.9     3.6 ± 0.8  
Glutammine deplection <20%   8 pt     3 pt  
Glutammine deplection >20%   5 pt     18 pt  
Glutammine increased   10 pt     2 pt  

Table 4: Pain scores, degree of satisfaction and glutamine levels.

Discussion

In the present study we found that in patients that underwent minor gynaecological surgery, the plasma levels of glutamine were significantly decreased, and that the pre-medication with betamethasone prevents the deplection of glutammine, improves postoperative pain and determines a better outcome of patients.

These findings seem to be in agreement with other studies performed by Carli and Emery [37]. In these studies, the authors found that the surgical procedures very often cause a robust decrease of glutamine or other free aminoacid. Moreover, they suggested that this effect was not related to the type of anesthesia carried out (although they have taken analysis of patients anesthetized with halothane or with an epidural block).

In contrast in a subsequent study Lattermann and colleagues [38] observed a significant reduction of muscular and protein catabolism with a decrease of plasmatic levels of glutamine larger than the group anesthetized with isoflurane that in the other one with subarachnoid anesthesia.

In this regard we previously found that the plasma Gln concentration after surgery was lower than pre surgery values and that in major surgery the decrease of Gln was higher than in minor surgery [39]. In this current study we discovered that minor gynaecological surgery also caused a significant decrease of plasma Gln in the majority of patients (32 patients out of 46). However, pre-medication with 4 mg betamethasone (i.v.) significantly prevented the observed decrease of Gln levels in the plasma levels after surgery. Importantly, we found significant differences in the post-operative pain’s score between the two groups of patients. In fact in 10 out of 23 patients belonging to the placebo group showed a VAS score >30, therefore paracetamol was administered to reduce the post-operative pain. In contrast, patients pre-medicated with betamethasone, did not require the use of analgesic drugs. A possible mechanism of glutamine on postoperative pain would depend of a connection between plasmatic decrease of glutamine and the increase of inflammatory cytokines released during surgery. As a consequence, we could think that premedication with Betametasone protected better the patient from surgical stress and from the following post-operative pain [21].

Moreover we found a correlation with the duration of the surgery and with parity, in fact in all 12 cases in which we observed a glutamine increase, the surgery lasted a short time, between 7 and 10 min. May be that a surgery lasting less, in a parous patient, and therefore less invasive, cannot cause a depletion of glutamine levels.

However, this study gives rise many questions.

Could the postoperative pain be reduced or prevented by direct glutamine administration? As also previously suggested [40].

The administration of analgesic drugs in pre-emptive can reduce body reaction to surgical stress and therefore glutamine depletion too, in postoperative?

In considering of result that shows an association between depletion of glutamine and pain in postoperative time, can the Gln be accepted in future as prognostic marker of postoperative pain?

Is there a difference in the Gln levels profile between men and women during surgeries? This also based on the evidence that in rat the sexual hormones differently affect visceral pain-related behavioral responses [41].

In conclusion, we suggest that it is important to increase the studies on the Gln profile in surgery and that the premedication with betamethasone can be an useful therapeutic opportunity to increase the plasma level of Gln during the minor surgeries, to reduce the post-operative pain and to ameliorate the satisfaction of the patients.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11713
  • [From(publication date):
    May-2015 - Nov 20, 2017]
  • Breakdown by view type
  • HTML page views : 7949
  • PDF downloads : 3764
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords